ExeVir Bio BV
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Dose-Finding, Safety, and Efficacy Study of XVR011 Added to Standard of Care in Patients Hospitalised for COVID-19 (NCT04884295) | ExeVir Bio BV | 2021-08-26 |
Track ExeVir Bio BV automatically
Every clearance here is in the API, with alerts when new ones post.